Balancing access to opioid substitution treatment (OST) with preventing the diversion of opioid substitution medications in Europe: challenges and implications 10. February 2021, section EUDA news
18. June 2026 EUDA annual activity report 2025: first full year under expanded mandate The European Union Drugs Agency (EUDA) today released its Consolidated Annual Activity Report 2025, capturing the...